Viseon announced FDA 510(k) clearance and initial clinical use of Voyant high-definition real-time imaging technology for minimally invasive spine surgery.
Molecular Matrix will enter into a strategic alliance with Philosys Healthcare to expand availability of bone graft substitute technology in the Asian market.
Active Implants was granted a Breakthrough Device Designation from FDA for the NUsurface® Meniscus Implant. If cleared by FDA, NUsurface would be the first artificial meniscus in the U.S. market.
The Orthopaedic Implant Company is participating in a pilot program which has led to a $3.6MM reduction in supply expenses for one integrated delivery network.Â
CoreLink is launching the Oro Lateral Plate to treat degenerative disc disease, spondylolisthesis, trauma and spinal deformities in the lumbar spine.